AMRA Medical continues to advance FSHD research with whole-body MRI measurements
LINKÖPING, Sweden, July 5, 2022 /PRNewswire/ -- AMRA Medical, a digital health company delivering a new standard in body composition analysis through rapid whole-body magnetic resonance imaging (MRI), today announced that the results of their Fulcrum-sponsored study highlighting the development and use of a whole-body MRI protocol for muscle analysis are now published in Neurology. The publication demonstrates how clinical investigators can use AMRA's MRI measurements to accurately and broadly capture the heterogeneity and progression of neuromuscular disorders like facioscapulohumeral muscular dystrophy (FSHD).
- In the study, AMRA shows that individual muscle measurements, whole-body composite scores, and functional composite measurements can help capture disease severity in individuals with FSHD.
- The research shows that functional composite measurements correlate with disease-relevant clinical outcome assessments such as reachable workspace (RWS) and timed-up-and-go (TUG).
- Using these measurements, they generated two types of composite scores per individual: (1) functional cross-sectional composite scores and (2) whole-body composite scores.
- Learn how AMRA can help you advance metabolic and musculoskeletal clinical research and development by visiting AMRA's website .